2. Academic Validation
  3. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin

In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin

  • Bull Exp Biol Med. 2018 Jun;165(2):220-224. doi: 10.1007/s10517-018-4134-6.
D V Kuzmin 1,  A A Emel'yanova 1,  M B Kalashnikova 1,  P V Panteleev 1,  T V Ovchinnikova 2
Affiliations

Affiliations

  • 1 M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • 2 M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia. ovch@ibch.ru.
PMID: 29922995 DOI: 10.1007/s10517-018-4134-6
Abstract

We studied combined effect of β-hairpin antimicrobial peptide tachyplesin I and cytotoxic agent cisplatin on tumor and normal human cell lines. MTT assay and flow cytometry showed that tachyplesin I selectively sensitized Cancer cells to cisplatin in specified concentration ratios. In vitro experiments demonstrated that combined use of tachyplesin I and cisplatin allows decreasing the effective dose of the cytostatic thus reducing nonspecific toxicity.

Keywords

antimicrobial peptide; cisplatin; cytotoxicity; effective dose; tachyplesin.

Figures
Products